UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000037182
Receipt number R000042369
Scientific Title Analysis of histone deacetylase inhibitory ability of food allergic children
Date of disclosure of the study information 2019/07/01
Last modified on 2023/06/29 18:32:50

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Analysis of histone deacetylase inhibitory ability of food allergic children

Acronym

Analysis of epigenetics in food allergic children

Scientific Title

Analysis of histone deacetylase inhibitory ability of food allergic children

Scientific Title:Acronym

Analysis of epigenetics in food allergic children

Region

Japan


Condition

Condition

Food allergy

Classification by specialty

Clinical immunology

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To confirm that HDAC inhibitory ability is useful as a prognostic marker for food allergy.

Basic objectives2

Others

Basic objectives -Others

Search for new biomarkers

Trial characteristics_1

Exploratory

Trial characteristics_2

Others

Developmental phase

Not applicable


Assessment

Primary outcomes

remission rate

Key secondary outcomes



Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

1 months-old <=

Age-upper limit

180 months-old >=

Gender

Male and Female

Key inclusion criteria

Children diagnosed with food allergy

Key exclusion criteria

Cases in which the doctor in charge judged that it was better to stop the examination.

Target sample size

10


Research contact person

Name of lead principal investigator

1st name Susumu
Middle name
Last name Yamazaki

Organization

Juntendo University Graduate School of Medicine

Division name

Department of Pediatrics and Adolescent Medicine

Zip code

113-8421

Address

2-1-1, Hongo, Bunkyo-ku, Tokyo 113-8421, Japan

TEL

0338133111

Email

susumu@juntendo.ac.jp


Public contact

Name of contact person

1st name Susumu
Middle name
Last name Yamazaki

Organization

Juntendo University Graduate School of Medicine

Division name

Department of Pediatrics and Adolescent Medicine

Zip code

113-8431

Address

2-1-1, Hongo, Bunkyo-ku, Tokyo 113-8421, Japan

TEL

0338133111

Homepage URL


Email

susumu@juntendo.ac.jp


Sponsor or person

Institute

Juntendo University Graduate School of Medicine

Institute

Department

Personal name



Funding Source

Organization

Jaoan society for the promotion of the sience

Organization

Division

Category of Funding Organization

Japanese Governmental office

Nationality of Funding Organization

JPN


Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Juntendo University

Address

2-1-1, Hongo, Bunkyo-ku, Tokyo 113-8421, Japan

Tel

0338133111

Email

susumu@juntendo.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2019 Year 07 Month 01 Day


Related information

URL releasing protocol

None

Publication of results

Unpublished


Result

URL related to results and publications

None

Number of participants that the trial has enrolled

6

Results

We investigated in food-allergic children, but there were many error values in each analysis value, and there was a wide range of control (adult cases), and no significant results were obtained.

Results date posted

2023 Year 06 Month 29 Day

Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics

food allergy child

Participant flow

Children who have given consent at an allergy outpatient clinic

Adverse events

None

Outcome measures

Blood butyric acid levels and histone deacetylase inhibitory activity

Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2019 Year 06 Month 01 Day

Date of IRB

2018 Year 06 Month 22 Day

Anticipated trial start date

2019 Year 07 Month 01 Day

Last follow-up date

2022 Year 03 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information

nothing


Management information

Registered date

2019 Year 06 Month 26 Day

Last modified on

2023 Year 06 Month 29 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000042369


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name